| Company Name: |
TCI Europe |
| Tel: |
320-37350700 |
| Email: |
sales@tcieurope.eu |
| Company Name: |
TCI AMERICA |
| Tel: |
800-4238616 |
| Email: |
sales@tciamerica.com |
- Amfonelic acid
-
- $33.00
-
2026-09-02
- CAS:15180-02-6
- Min. Order: 1kg
- Purity: 99%
- Amfonelic acid
-
-
2026-06-30
- CAS:15180-02-6
- Min. Order: 1KG
- Purity: 98
- Supply Ability: 10000KGS
|
| | Amfonelic acid Basic information |
| Product Name: | Amfonelic acid | | Synonyms: | AMFONELIC ACID;1,8-Naphthyridine-3-carboxylicacid, 1-ethyl-1,4-dihydro-4-oxo-7-(phenylMethyl)-;1-Ethyl-1,4-dihydro-4-oxo-7-(phenylmethyl)-1,8-naphthyridine-3-carboxylic acid;AMFONELIC ACID INCREASES DOPAMINE RE;amfonelic acid (7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid);7-Benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid;NSC-100638;WIN-25978 | | CAS: | 15180-02-6 | | MF: | C18H16N2O3 | | MW: | 308.33 | | EINECS: | 605-001-5 | | Product Categories: | | | Mol File: | 15180-02-6.mol |  |
| | Amfonelic acid Chemical Properties |
| Melting point | >1000 °C | | Boiling point | 499℃ | | density | 1.297 | | Fp | 256℃ | | solubility | 0.1 M NaOH: soluble | | form | powder | | pka | 3.50±0.20(Predicted) | | color | yellow | | InChI | InChI=1S/C18H16N2O3/c1-2-20-11-15(18(22)23)16(21)14-9-8-13(19-17(14)20)10-12-6-4-3-5-7-12/h3-9,11H,2,10H2,1H3,(H,22,23) | | InChIKey | WHHHJDGNBVQNAU-UHFFFAOYSA-N | | SMILES | N1(CC)C2C(=CC=C(CC3=CC=CC=C3)N=2)C(=O)C(C(O)=O)=C1 |
| Hazard Codes | Xn | | Risk Statements | 40-43 | | Safety Statements | 36/37 | | WGK Germany | 3 | | HS Code | 2933.99.8290 |
| | Amfonelic acid Usage And Synthesis |
| Description | Amfonelic acid, a derivative of nalidixic acid, was originally developed as a central nervous system stimulant. It is a highly potent nonamphetamine stimulant whose actions are inhibited by reserpine but not by the tyrosine hydroxylase inhibitor, a-methyltyrosine. Additionally, it enhances the impacts of antipsychotic medicines such as haloperidol, trifluoperazine, and spiperone. | | Uses | Amfonelic acid (AFA) is a dopamine reuptake inhibitor, that has marked effects on brain dopamine metabolism but not noradrenaline metabolism. Experiments on rats have shown that AFA treatment completely prevented the effects of methamphetamine on the dopaminergic system, both morphologically and biochemically. Rats are shown to self-administer amfonelic acid in a dose-dependent manner. | | Biological Activity | Amfonelic acid (AFA), an inhibitor of dopamine (DA) uptake, has been found to increase the levels of tryptophan (TRYP) and 5-hydroxyindoleacetic acid (5-HIAA) in the rat c. striatum, cerebral cortex, and brain stem. The duration of action of the effect of AFA on TRYP and 5-HIAA appeared to be longer than that of the increase of the striatal DA metabolites homovanillic acid and 3,4-dihydroxyphenylacetic acid[1]. | | References | The effects of amfonelic acid alone and in combination with naloxone on brain-stimulation reward DOI: 10.1016/0091-3057(89)90069-5
Pharmacologic properties and mechanism of action of amfonelic acid DOI: 10.1016/0014-2999(70)90206-2
| | References |
[1] P C Waldmeier. “The effects of amfonelic acid on 5-HT metabolism in rat brain.” Journal of Neural Transmission 57 3 (1983): 149–65.
|
| | Amfonelic acid Preparation Products And Raw materials |
|